Nephros (NEPH) EBIT (QoQ) (2010 - 2026)
Nephros (NEPH) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.32 Bn | 129.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.44 Bn | 51.58 Bn | 2.32 Bn |
| 3 | Alcon | 35.73 Bn | 34.38 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.08 Bn | 26.41 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.02 Bn | 24.58 Bn | 329.20 Mn |
| 7 | Solventum | 15.39 Bn | 14.99 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.80 Bn | 14.66 Bn | 735.40 Mn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn |
| 10 | Nephros | 44.51 Mn | 39.81 Mn | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,150.52% |
| Mar 31, 2026 | 438.89% |
| Dec 31, 2025 | -94.27% |
| Sep 30, 2025 | 26.61% |
| Jun 30, 2025 | -56.18% |
| Mar 31, 2025 | 78.55% |
| Dec 31, 2024 | 53.88% |
| Sep 30, 2024 | 164.98% |
| Jun 30, 2024 | -58.50% |
| Mar 31, 2024 | 69.18% |
| Dec 31, 2023 | -219.70% |
| Sep 30, 2023 | 53.33% |
| Jun 30, 2023 | -42.16% |
| Mar 31, 2023 | 55.84% |
| Dec 31, 2022 | 45.90% |
| Sep 30, 2022 | -57.37% |
| Jun 30, 2022 | 47.38% |
| Mar 31, 2022 | -114.56% |
| Dec 31, 2021 | 10.10% |
| Sep 30, 2021 | 28.20% |